Market Overview

UPDATE: Longbow Upgrades Chemtura to Buy on Margin Enhancement and Portfolio Evolution

Related CHMT
Chemtura to Sell Consumer Products Unit to KIK for $315M, Exploring Possible Sale of Agrochemicals Unit
Chemtura Announces Offering of $400 Million of Senior Notes Due 2021

Longbow raised its rating on Chemtura (NYSE: CHMT) from Neutral to Buy with a $26 price target.

Longbow commented, "We are upgrading our investment rating of CHMT to BUY from NEUTRAL with a 12-month target price of $26 on greater confidence in management's ability to outperform expectations in the near-term. Sustainable improvements in AgroSolutions, a compelling strategic rationale for the Solaris deal and expectations of further growth in Engineered Products, combined with further portfolio optimization should generate meaningful shareholder value expansion over a 12-24 month period."

Chemtura closed at $20.44 on Wednesday.

Posted-In: LongbowAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Most Popular

Related Articles (CHMT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free